Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Minocycline Foam for CARP
NCT07462702Phase 1Not yet recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2026
- Primary completion
- Aug 2027
- Modality
- Transdermal Patches, Small Molecules
01
Overview
Phase 1, single-blind trial of zilxi in confluent and reticulated papillomatosis (CARP) (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Change in analog score based on blinded reviewer analysis at 5 weeks. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
zilxi
03
Conditions
confluent and reticulated papillomatosis (CARP)
Beyond the preview
Go deeper on NCT07462702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07462702.